focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 445.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 30.00 (6.977%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 445.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares and Director Dealing

22 Apr 2016 07:00

RNS Number : 0235W
BrainJuicer Group PLC
22 April 2016
 

 

 

 

Press Release

22 April 2016

BrainJuicer Group PLC (AIM: BJU)

("BrainJuicer" or "the Company")

 

Transaction in Own Shares and Director Dealing

 

BrainJuicer, the international market research agency, announces that it yesterday purchased 422,762 ordinary shares into Treasury pursuant to the Company's share buy-back announced on 31 March 2016 (the "Buyback"), at a price of 332.5 pence per share.

 

John Kearon, Chief Executive Officer, yesterday sold a total of 500,000 shares at a price of 332.5 pence per share.

 

As a result of the above transactions: (1) the Company holds 932,030 ordinary shares in Treasury, and its total number of ordinary shares with voting rights has declined to 12,291,732; and (2) John Kearon is beneficially interested in 3,359,996 ordinary shares, representing 27.34% of the voting rights of the Company.

 

As noted in the announcement on 31 March, any shareholders wishing to participate in the Buyback should contact the Company's broker Canaccord Genuity Limited. The Buyback will be undertaken until the earlier of all 1 million ordinary shares being repurchased and the Company's 2016 Annual General Meeting on 6 May 2016.

 

The Company further notes that the executive director LTIP performance measures relating to earnings per share will be adjusted for the shares purchased under the Buyback, so that the earnings per share performance targets are no easier to achieve than they would have been had the Buyback not taken place.

 

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buyback.

 

Related Party Transaction

As the vendor of the 422,762 ordinary shares purchased by the Company, at 332.5 pence per share, is John Kearon, Chief Executive Officer of the Company, this transaction is a related party transaction pursuant to AIM Rule 13. The directors of the Company, having consulted with the Company's nominated adviser, Canaccord Genuity Limited, consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

 

For further information, please contact:

BrainJuicer Group PLC

 +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

James Geddes, Chief Financial Officer

Canaccord Genuity Limited (Nomad)

+44 (0)20 7523 8000

Simon Bridges / Henry Fitzgerald-O'Connor / Emma Gabriel

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEFSIEFMSEDL
Date   Source Headline
30th Jun 20224:15 pmRNSHolding(s) in Company
30th Jun 20229:30 amRNSHolding(s) in Company
27th Jun 20223:00 pmRNSDirectorate Change
22nd Jun 20227:00 amRNSDistribution policy
6th Jun 20227:00 amRNSHolding(s) in Company
26th May 20221:15 pmRNSDirectorate Change
13th May 202212:15 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSTrading Update
1st Apr 20222:00 pmRNSCompletion of Share Buyback Programme
25th Mar 20225:21 pmRNSTransaction in Own Shares
23rd Mar 20223:30 pmRNSTransaction in Own Shares
22nd Mar 20225:32 pmRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSUpdate re Stefan Barden
11th Mar 20226:00 pmRNSTransaction in Own Shares
11th Mar 20223:30 pmRNSHolding(s) in Company
4th Mar 20226:25 pmRNSTransaction in Own Shares
4th Mar 202210:15 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20224:15 pmRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTrading Update
21st Feb 20223:15 pmRNSTransaction in Own Shares
18th Feb 20225:31 pmRNSTransaction in Own Shares
16th Feb 20225:30 pmRNSTransaction in Own Shares
15th Feb 202210:15 amRNSTransaction in Own Shares
14th Feb 20225:02 pmRNSTransaction in Own Shares
11th Feb 20225:15 pmRNSTransaction in Own Shares
9th Feb 20223:45 pmRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTrading Update
4th Feb 202211:45 amRNSHolding(s) in Company
24th Jan 20225:50 pmRNSTransaction in Own Shares
21st Jan 20225:15 pmRNSTransaction in Own Shares
20th Jan 20225:15 pmRNSTransaction in Own Shares
12th Jan 202212:30 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.